Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Adenocarcinoma of Lung × palbociclib × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Breast Neoplasms 3 Pancreatic Neoplasms 2 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Glioblastoma 1 Colorectal Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

palbociclib 1 dapagliflozin 1 binimetinib 1 Specimen Handling 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04870034 2023-12-22

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Withdrawn

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡